Anti-Human IL1Beta Recombinant Antibody (Canakinumab) (CAT#: TAB-021)

Recombinant monoclonal antibody to Human IL1 beta. Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
Canakinumab was for the treatment of rheumatoid arthritis. Canakinumab is as a possible treatment for chronic obstructive pulmonary disease, gout and coronary artery disease.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • Publications
  • COA
ELISA

Figure 1 Human IL1 Beta Therapeutic Antibody (TAB-021) in ELISA

Figure 1 Human IL1 Beta Therapeutic Antibody (TAB-021) in ELISA

ELISA analysis of TAB-021 was performed by coating with Recombinant Human IL1 Beta.

WB

Figure 2 Human IL1 Beta Therapeutic Antibody (TAB-021) in WB

Figure 2 Human IL1 Beta Therapeutic Antibody (TAB-021) in WB

Western blot analysis of TAB-021 was performed with Recombinant Human IL1 Beta.
Lane 1: Non-Reducing Antigen (1ug)
Lane 2: Reducing Antigen (1ug)


Specifications

  • Immunogen
  • Recombinant human ILI beta
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FC, IP, ELISA, Neut, FuncS, IF, IHC and most other immunological methods.
  • Trade name
  • ilaris
  • CAS
  • 914613-48-2
  • Generic Name
  • Canakinumab
  • ATC Code
  • L04AC08
  • DrugBank
  • DB06168
  • UNII
  • 37CQ2C7X93
  • ChEMBL
  • CHEMBL1201834
  • MW
  • 145.2 kDa
  • Related Disease
  • Rheumatoid arthritis (RA)

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Target

  • Alternative Names
  • Canakinumab;ilaris;914613-48-2;ACZ885;DB06168Catabolin;H1;Hematopoietin 1;IFN beta inducing factor;IL 1;IL 1 beta;IL 1B;IL-1 beta;IL1 BETA;IL1F2;Interleukin 1 beta;Interleukin 1 beta precursor;Interleukin-1 beta;LAF;OAF;Osteoclast activating factor;OTTHUM

Related Resources

  • Biosimilar Overview
  • Related Diseases
  • Related Signaling Pathways
Please refer to Canakinumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Canakinumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Canakinumab"

Afuco™ Anti-IL1B ADCC Recombinant Antibody (Canakinumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human IL1 beta. Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
Canakinumab was for the treatment of rheumatoid arthritis. Canakinumab is as a possible treatment for chronic obstructive pulmonary disease, gout and coronary artery disease.

See other products for "IL1B"

Chimeric Antibody

CAT Product Name Application Type
TAB-232CT Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody (ch47F11) Inhibition Chimeric antibody (mouse/human)
TAB-237CT Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody (chSK48-E26) ELISA, Neut Chimeric antibody (mouse/human)
TAB-543LC Anti-human IL1B Recombinant Antibody, Chimeric (TAB-543LC) ELISA Chimeric antibody (mouse/human)
TAB-543LC-S(P) Anti-human IL1B scFv Fragment, Chimeric ELISA Chimeric antibody (mouse/human)
TAB-543LC-F(E) Anti-human IL1B Fab Fragment, Chimeric ELISA Chimeric antibody (mouse/human)

Chicken IgY Antibody

CAT Product Name Application Type
BRD-0282MZ Chicken Anti-Interleukin-1β Polyclonal IgY WB, Indirect ELISA Chicken antibody

Blocking Antibody

CAT Product Name Application Type
NEUT-1274CQ Mouse Anti-IL1B Recombinant Antibody (clone B-A15) Block, FC Mouse IgG1
NEUT-1285CQ Mouse Anti-IL1B Recombinant Antibody (clone H1b-27) ELISA, ELISPOT, Block Mouse IgG2b, κ

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-021 Afuco™ Anti-IL1B ADCC Recombinant Antibody (Canakinumab), ADCC Enhanced ELISA, IP, FC, FuncS, Neut ADCC enhanced antibody
AFC-TAB-161 Afuco™ Anti-IL1B ADCC Recombinant Antibody (Gevokizumab), ADCC Enhanced ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-021. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare